Sidanis Pharma
Pre-clinicalSidanis is a biopharmaceutical start-up enterprise focusing on innovative therapies to prevent and treat infectious diseases in human and animal health.
Founded
2018
Focus
Small Molecules
About
Sidanis is a biopharmaceutical start-up enterprise focusing on innovative therapies to prevent and treat infectious diseases in human and animal health.
Funding History
1Total raised: $1.8M
Seed$1.8MHigh-Tech GründerfondsJun 15, 2019
Company Info
TypePrivate
Founded2018
LocationBerlin, Germany
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile